Clindamycin 1% Gel

DRUG3 trials

Sponsors

Wake Forest University, University of Southern California, Akorn, Inc.

Conditions

Acne VulgarisSurgical Site Infection

Phase 2

Topical Treatment and Prevalence of P. Acnes

CompletedNCT03257202

University of Southern CaliforniaSurgical Site Infection

Start: 2017-09-11End: 2018-01-01Updated: 2019-11-13

Phase 3

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

CompletedNCT03522441

Akorn, Inc.Acne Vulgaris

Start: 2018-04-27End: 2019-04-22Updated: 2020-10-05

Phase 4

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

CompletedNCT01047189

Wake Forest UniversityAcne Vulgaris

Start: 2009-03-31End: 2009-10-31Updated: 2018-09-10